APA (7th ed.) Citation

C, S., G, S., V, J., M, S., R, F., C, B., . . . W, H. (2025). Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: Results of a phase II study from the German Lymphoma Alliance. Haematologica, 110(12), 3022. https://doi.org/10.3324/haematol.2024.287162

Chicago Style (17th ed.) Citation

C, Schmidt, et al. "Chemotherapy-free Combination of Ibrutinib and Obinutuzumab for Untreated Advanced Follicular Lymphoma: Results of a Phase II Study from the German Lymphoma Alliance." Haematologica 110, no. 12 (2025): 3022. https://doi.org/10.3324/haematol.2024.287162.

MLA (9th ed.) Citation

C, Schmidt, et al. "Chemotherapy-free Combination of Ibrutinib and Obinutuzumab for Untreated Advanced Follicular Lymphoma: Results of a Phase II Study from the German Lymphoma Alliance." Haematologica, vol. 110, no. 12, 2025, p. 3022, https://doi.org/10.3324/haematol.2024.287162.